about
Vaccines for preventing malaria (blood-stage)Vaccines for preventing malaria (SPf66)Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionPrimaquine for reducing Plasmodium falciparum transmissionOral vaccines for preventing choleraOral vaccines for preventing choleraVaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)Primaquine for reducing transmission of Plasmodium falciparum malariaVaccines for preventing anthraxVaccines for preventing malaria (pre-erythrocytic)WITHDRAWN: Vaccines for preventing malaria.Vaccines for preventing malariaThe benefits of artemisinin combination therapy for malaria extend beyond the individual patientNaturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assayMosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersSeroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administrationLymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the EndgameRapid increase in ownership and use of long-lasting insecticidal nets and decrease in prevalence of malaria in three regional States of ethiopia (2006-2007).Analysis of malaria surveillance data in Ethiopia: what can be learned from the Integrated Disease Surveillance and Response System?Risk factors for anemia in children under 6 years of age in Ethiopia: analysis of the data from the cross-sectional Malaria IndicatorSurvey, 2007.Integrating an NTD with one of "The big three": combined malaria and trachoma survey in Amhara Region of Ethiopia.Malaria prevalence and mosquito net coverage in Oromia and SNNPR regions of Ethiopia.Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.Knowledge of malaria and its association with malaria-related behaviors--results from the Malaria Indicator Survey, Ethiopia, 2007.Prevention of type 1 diabetes from laboratory to public health.Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions.Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.Identification and control of an isolated, but intense focus of lymphatic filariasis on Satawal Island, Federated States of Micronesia, in 2003.Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu.Vaccines for preventing cholera.Vaccines for preventing anthrax.Vaccines for preventing tick-borne encephalitis.Performance of local light microscopy and the ParaScreen Pan/Pf rapid diagnostic test to detect malaria in health centers in Northwest EthiopiaWhich nets are being used: factors associated with mosquito net use in Amhara, Oromia and Southern Nations, Nationalities and Peoples' Regions of Ethiopia.Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, NigeriaEvaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan VillageFactors associated with mosquito net use by individuals in households owning nets in Ethiopia.Surgical Treatment of Genital Manifestations of Lymphatic Filariasis: A Systematic Review.Determinants of Bed Net Use in Southeast Nigeria following Mass Distribution of LLINs: Implications for Social Behavior Change Interventions.
P50
Q21032518-9D75B8C0-1532-4D93-A2B8-FD7D05E3CC06Q21032526-24329C2C-2438-4424-AE23-1100BF0E5368Q24188070-A0E72321-B19D-41AD-B815-1949AB40609AQ24193716-7D9ADFD7-FE87-4B81-9674-103A50C4633FQ24200471-9E1D3AC4-81EB-4446-95D8-32CEE086482AQ24234435-2C23872A-03E1-4C4D-BA88-698A131C3E57Q24235775-33129A79-40F4-4731-8501-4D168BF575B7Q24236264-3F8D1F23-FA51-4EAD-883F-8501C448AA3DQ24241596-F16ACEAA-FA10-4360-BDA2-E138160F79BEQ24243247-C3355D0B-1D61-4FCE-9C6E-1C2B1B5B02F6Q24244317-CBDBDC0D-0660-4681-9F2C-409710FAFB52Q24244392-AAA56443-8D73-4EE7-9407-0EDEC3A46E18Q24250252-440AD865-E3C3-41A6-8295-9B1A9A3D12CCQ24250252-951430B5-06FB-49A7-B7F9-CBC2818050B2Q24792313-1896DE34-C029-499E-8139-26AAB6EBEA6FQ27487442-E029BC16-A239-43A5-9595-408FBC0D71B7Q28482471-25A2A663-8657-48E6-998B-EB29F17195D2Q28544925-644E26DA-2DA8-495F-80F9-6D964B413134Q28553089-0C9027D2-9465-4FBD-971E-E36F703AC516Q30062546-35D159EE-36E7-42D0-8F5E-E7B4D0A7FACBQ30566757-7F8CA600-E514-471E-ACC6-E1B28B5BAF21Q30692855-AA520DCC-D257-4C70-B443-2F74A4E8FCAEQ33324376-BD80468C-0158-4C6E-A639-EC1B3472C877Q33370716-50121C4E-F9F2-450F-A97D-14B9CD7A768AQ33626090-8853D66A-9922-4F2F-98B4-7571291C901CQ33640252-337F0E70-6BFF-40DB-BEF5-0EEE1F17BA99Q33703110-1EB5166F-EEBE-44A1-9080-6982A5B7B4CDQ33737331-F990B880-FA35-427B-810C-1AE1218225E4Q33750542-CE0811FF-EAB1-4A97-9938-DDC2C3CA7ED9Q33781636-BBFA313E-11C0-441B-80AF-02FF8581266BQ33805156-5ED1671C-AB50-4931-8B5A-0D8CEB368128Q33908873-571D1A57-D9D3-45E0-A72E-C602A25C4215Q33908878-EE8D0476-0AD1-4684-BFF8-1CC817DF0478Q33908884-5FB31D5A-BE5F-4CBE-8EED-A38D44D78C83Q34247015-D97908C7-D13F-4EA4-90B3-BA42734D76F1Q35023700-BFFE5239-1C9B-4200-B4FB-F25376B5307AQ35131779-D315834E-2E27-4756-BD99-BB14DCCF92CFQ35668102-B9B40B7A-E6A6-4786-A987-D541E3C44B41Q35672609-796B5A7B-4361-4FF8-A823-FC83F31B0E05Q35759590-85D9A7DC-DD03-4F94-9955-B94D154211A2
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Patricia Graves
@fr
Patricia M Graves
@nl
Patricia M Graves
@sl
Patricia M. Graves
@en
Patricia M. Graves
@es
type
label
Patricia Graves
@fr
Patricia M Graves
@nl
Patricia M Graves
@sl
Patricia M. Graves
@en
Patricia M. Graves
@es
altLabel
P Graves
@en
PM Graves
@en
Patricia M Graves
@en
prefLabel
Patricia Graves
@fr
Patricia M Graves
@nl
Patricia M Graves
@sl
Patricia M. Graves
@en
Patricia M. Graves
@es
P1053
J-8691-2014
P106
P1153
7103177508
P21
P214
2080153472512845360007
P31
P3829
P3835
patricia-m-graves
P496
0000-0002-5215-3901
P734
P735
P7859
viaf-2080153472512845360007